Expression of Transgenic APP mRNA Is the Key Determinant for Beta-Amyloid Deposition in PS2APP Transgenic Mice
Year: 2008
Type: article
Source: Neurodegenerative Diseases
DOI: 10.1159/000170884
Institution: F. Hoffmann-La Roche AG
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2070711680
